Julie Satterwhite

2.2k total citations
15 papers, 1.6k citations indexed

About

Julie Satterwhite is a scholar working on Physiology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Julie Satterwhite has authored 15 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Oncology and 4 papers in Orthopedics and Sports Medicine. Recurrent topics in Julie Satterwhite's work include Bone health and osteoporosis research (4 papers), Bone health and treatments (3 papers) and Alzheimer's disease research and treatments (3 papers). Julie Satterwhite is often cited by papers focused on Bone health and osteoporosis research (4 papers), Bone health and treatments (3 papers) and Alzheimer's disease research and treatments (3 papers). Julie Satterwhite collaborates with scholars based in United States, United Kingdom and France. Julie Satterwhite's co-authors include Ouhong Wang, Robert Marcus, Bruce Mitlak, Martin R. Farlow, Eric Siemers, Patrick C. May, Celedon Gonzales, Adrien Sipos, E. Michael Lewiecki and Rachel B. Wagman and has published in prestigious journals such as New England Journal of Medicine, Neurology and Journal of Bone and Mineral Research.

In The Last Decade

Julie Satterwhite

15 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie Satterwhite United States	12	539	503	501	473	269	15	1.6k
Michael W. Draper United States	18	429 0.8×	144 0.3×	395 0.8×	406 0.9×	32 0.1×	34	1.6k
David R. Powell United States	27	1.0k 1.9×	338 0.7×	145 0.3×	35 0.1×	133 0.5×	39	2.6k
Yalda Jamshidi United Kingdom	20	647 1.2×	259 0.5×	86 0.2×	143 0.3×	38 0.1×	38	1.3k
Catia Pilon Italy	22	418 0.8×	478 1.0×	62 0.1×	55 0.1×	179 0.7×	37	1.7k
Mariette Barthelmebs France	22	478 0.9×	214 0.4×	182 0.4×	24 0.1×	82 0.3×	96	1.3k
Prem Gurnani United States	11	858 1.6×	471 0.9×	68 0.1×	33 0.1×	83 0.3×	20	2.5k
Stephanie Siu Canada	10	220 0.4×	140 0.3×	94 0.2×	28 0.1×	298 1.1×	13	1.3k
Victor Dosenko Ukraine	18	431 0.8×	233 0.5×	37 0.1×	65 0.1×	47 0.2×	156	1.2k
Masaki Nakayama Japan	17	550 1.0×	118 0.2×	116 0.2×	164 0.3×	10 0.0×	36	1.3k
Kuniko Horie Japan	20	743 1.4×	144 0.3×	116 0.2×	19 0.0×	52 0.2×	45	1.4k

Countries citing papers authored by Julie Satterwhite

Since Specialization

Citations

This map shows the geographic impact of Julie Satterwhite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Satterwhite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Satterwhite more than expected).

Fields of papers citing papers by Julie Satterwhite

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Satterwhite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Satterwhite. The network helps show where Julie Satterwhite may publish in the future.

Co-authorship network of co-authors of Julie Satterwhite

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Satterwhite. A scholar is included among the top collaborators of Julie Satterwhite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Satterwhite. Julie Satterwhite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Satterwhite, Julie, et al.. (2014). Population exposure-response model to support dosing evaluation of ixekizumab in patients with chronic plaque psoriasis. The Journal of Clinical Pharmacology. 54(10). 1117–1124. 26 indexed citations

Genovese, Mark C., Eric Lee, Julie Satterwhite, et al.. (2013). A phase 2 dose-ranging study of subcutaneous tabalumab for the treatment of patients with active rheumatoid arthritis and an inadequate response to methotrexate. Annals of the Rheumatic Diseases. 72(9). 1453–1460. 41 indexed citations

Genovese, Mark C., Roy Fleischmann, Maria Greenwald, et al.. (2012). Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors. Annals of the Rheumatic Diseases. 72(9). 1461–1468. 56 indexed citations

Jesudason, Cynthia D., James E. Baker, Libbey S. O′Farrell, et al.. (2011). Combination of a Beta Adrenoceptor Modulator and a Norepinephrine-Serotonin Uptake Inhibitor for the Treatment of Obesity. ACS Medicinal Chemistry Letters. 2(8). 583–586. 2 indexed citations

Satterwhite, Julie, Michael Heathman, Paul D. Miller, et al.. (2010). Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis. Calcified Tissue International. 87(6). 485–492. 79 indexed citations

Greenfield, Jerry R., Jeffrey W. Miller, Julia M. Keogh, et al.. (2008). Modulation of Blood Pressure by Central Melanocortinergic Pathways. New England Journal of Medicine. 360(1). 44–52. 360 indexed citations

Siemers, Eric, Joseph F. Quinn, Jeffrey Kaye, et al.. (2006). Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease. Neurology. 66(4). 602–604. 220 indexed citations

Siemers, Eric, Michael Skinner, Robert A. Dean, et al.. (2005). Safety, Tolerability, and Changes in Amyloid β Concentrations After Administration of a γ-Secretase Inhibitor in Volunteers. Clinical Neuropharmacology. 28(3). 126–132. 171 indexed citations

Chen, Peiqi, Julie Satterwhite, Angelo A. Licata, et al.. (2005). Early Changes in Biochemical Markers of Bone Formation Predict BMD Response to Teriparatide in Postmenopausal Women With Osteoporosis. Journal of Bone and Mineral Research. 20(6). 962–970. 244 indexed citations

10.

Farlow, Martin R., Robert A. Dean, Julie Satterwhite, Patrick C. May, & Eric Siemers. (2004). P4-361 Determination of abeta concentrations in serial samples of human cerebrospinal fluid. Neurobiology of Aging. 25. S577–S578. 5 indexed citations

11.

Siemers, Eric, Robert A. Dean, Julie Satterwhite, et al.. (2004). P4-333 Safety, tolerability, and changes in plasma and cerebrospinal fluid amyloid beta concentrations after administration of a functional gamma-secretase inhibitor in healthy volunteers. Neurobiology of Aging. 25. S569–S570. 14 indexed citations

12.

Frolik, Charles A., et al.. (2003). Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone. 33(3). 372–379. 162 indexed citations

13.

Marcus, Robert, Ouhong Wang, Julie Satterwhite, & Bruce Mitlak. (2003). The Skeletal Response to Teriparatide Is Largely Independent of Age, Initial Bone Mineral Density, and Prevalent Vertebral Fractures in Postmenopausal Women With Osteoporosis. Journal of Bone and Mineral Research. 18(1). 18–23. 165 indexed citations

14.

Bodick, N., Walter Offen, H E Shannon, et al.. (1997). The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.. PubMed. 11 Suppl 4. S16–22. 89 indexed citations

15.

Jackson, Charles V., et al.. (1996). Preclinical and Clinical Pharmacology of Efegatran (LY294468) : A Novel Antithrombin for the Treatment of Acute Coronary Syndromes. Clinical and Applied Thrombosis/Hemostasis. 2(4). 258–267. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact